Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.

Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, Vlachos HA, Schwartz L, Frye RL, Kelsey SF, Waseda K, Hlatky MA; BARI-2D Study Group..

J Am Coll Cardiol. 2017 Jan 31;69(4):395-403. doi: 10.1016/j.jacc.2016.10.067.

PMID:
28126156
2.

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group..

N Engl J Med. 2015 Aug 13;373(7):610-20. doi: 10.1056/NEJMoa1415921.

3.

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ.

Acta Diabetol. 2016 Apr;53(2):243-50. doi: 10.1007/s00592-015-0770-8. Epub 2015 May 24.

4.

The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.

Pambianco G, Costacou T, Strotmeyer E, Orchard TJ.

Diabetes Res Clin Pract. 2011 May;92(2):280-7. doi: 10.1016/j.diabres.2011.02.005. Epub 2011 Mar 15.

5.

The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Singh PP, Abbott JD, Lombardero MS, Sutton-Tyrrell K, Woodhead G, Venkitachalam L, Tsapatsaris NP, Piemonte TC, Lago RM, Rutter MK, Nesto RW; Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group..

Diabetes Care. 2011 Feb;34(2):464-7. doi: 10.2337/dc10-1734.

6.

Risk factor associations with clinical distal symmetrical polyneuropathy and various neuropathy screening instruments and protocols in type 1 diabetes.

Pambianco G, Costacou T, Strotmeyer E, Orchard TJ.

Diabetes Res Clin Pract. 2011 Jan;91(1):e15-20. doi: 10.1016/j.diabres.2010.09.031. Epub 2010 Oct 28.

7.

Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with Type 1 diabetes?

Lloyd CE, Pambianco G, Orchard TJ.

Diabet Med. 2010 Feb;27(2):234-7. doi: 10.1111/j.1464-5491.2009.02896.x.

8.

A randomized trial of therapies for type 2 diabetes and coronary artery disease.

BARI 2D Study Group., Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE.

N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7.

9.

Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.

Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators..

J Peripher Nerv Syst. 2009 Mar;14(1):1-13. doi: 10.1111/j.1529-8027.2009.00200.x.

10.

Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Pambianco G, Lombardero M, Bittner V, Forker A, Kennedy F, Krishnaswami A, Mooradian AD, Pop-Busui R, Rana JS, Rodriguez A, Steffes M, Orchard TJ.

Prev Cardiol. 2009 Winter;12(1):9-18.

11.

Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group..

Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. doi: 10.1016/j.ahj.2008.05.015. Epub 2008 Jul 31.

13.

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes: response to Dyck et al.

Orchard TJ, Costacou T, Miller RG, Prince CT, Pambianco G.

Diabetes Care. 2007 Feb;30(2):448; author reply 448-9. No abstract available.

PMID:
17259536
14.

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.

Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ.

Diabetes. 2006 May;55(5):1463-9.

15.

Hypertension as a risk factor for diabetic neuropathy: a prospective study.

Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ.

Diabetes. 1997 Apr;46(4):665-70.

PMID:
9075809
16.

Deep vein thrombosis: prevention in stroke patients during rehabilitation.

Pambianco G, Orchard T, Landau P.

Arch Phys Med Rehabil. 1995 Apr;76(4):324-30.

PMID:
7717832
17.

Accuracy and reliability of the Caltrac accelerometer for estimating energy expenditure.

Pambianco G, Wing RR, Robertson R.

Med Sci Sports Exerc. 1990 Dec;22(6):858-62.

PMID:
2287266
18.

The assessment of historical physical activity and its relation to adult bone parameters.

Kriska AM, Sandler RB, Cauley JA, LaPorte RE, Hom DL, Pambianco G.

Am J Epidemiol. 1988 May;127(5):1053-63.

PMID:
3358406
19.

A two year randomized exercise trial in older women: effects on HDL-cholesterol.

Cauley JA, Kriska AM, LaPorte RE, Sandler RB, Pambianco G.

Atherosclerosis. 1987 Aug;66(3):247-58.

PMID:
3307795
20.

A randomized exercise trial in older women: increased activity over two years and the factors associated with compliance.

Kriska AM, Bayles C, Cauley JA, LaPorte RE, Sandler RB, Pambianco G.

Med Sci Sports Exerc. 1986 Oct;18(5):557-62.

PMID:
3534509

Supplemental Content

Loading ...
Support Center